相关实验视频
Updated: Jun 23, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.4K
迪奥斯梅丁:一种饮食中的黄作为癌症进展中信号通路的调节器
Waseem Raza1,2, Abha Meena1,3, Suaib Luqman1,3
1Bioprospection and Product Development Division, CSIR-Central Institute of Medicinal and Aromatic Plants, Lucknow, India.
Molecular carcinogenesis
|June 18, 2024
概括
一种黄类化合物迪奥斯梅丁通过调节细胞周期,诱导细胞亡和抑制各种癌症的瘤进展,显示出显著的抗癌潜力. 对纳米配方的进一步研究可以提高其临床效用.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 黄类是一种主要的多类,有超过9000种已识别的化合物.
- 来自迪奥斯的O-甲基化黄 diosmetin正因其生物活性而引起人们的注意.
- 包括迪奥斯梅丁在内的黄类药物已证明对各种癌细胞类型具有细胞毒性作用.
研究的目的:
- 为了审查diosmetin的抗癌潜力.
- 阐明迪奥斯梅丁在癌症中的作用机制.
- 分析迪奥斯梅丁在不同类型癌症中的疗效及其临床应用潜力.
主要方法:
- 关于迪奥斯梅丁抗癌特性研究的综合文献综述.
- 分析包括细胞循环调节,细胞亡,自和转移抑制等机制.
- 在体外和体内 (异种移植小鼠) 研究的评估.
- 综合疗法,自然来源,药理动力学和毒性的评估.
主要成果:
- 迪奥斯梅丁通过诱导亡 (内在和外在途径),细胞循环停止,以及抑制瘤进展和转移,表现出抗癌作用.
- 在乳腺,结肠,肝脏,质瘤,白血病,肺癌,前列腺癌和皮肤癌中观察到迪奥斯梅丁的疗效.
- 纳米配方有望克服迪奥斯梅丁的可溶性和透性限制,以提高临床效用.
结论:
- 迪奥斯梅丁是癌症治疗的有希望的化合物,因为它具有多方面的抗癌机制.
- 组合研究和纳米配方是提高迪奥斯梅丁治疗效率和降低毒性的关键策略.
- 需要进一步的研究和临床试验,才能充分发挥迪奥斯梅丁在瘤学中的潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Non-Canonical Wnt Signaling Pathways
7.3K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K

